Dr. Jeffrey John Cavendish, MD

Dr. Cavendish practices at Scripps Memorial Hospital La Jolla in La Jolla, California, part of Scripps Health.

Dr. Cavendish's NPI, 1093787889, was assigned on February 6, 2006. Dr. Cavendish graduated from Georgetown University School Of Medicine in 1994. Dr. Cavendish holds California license A83079.

Dr. Cavendish's primary practice is Scripps Memorial Hospital La Jolla, at 9888 Genesee Avenue, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 626-4123.

Dr. Cavendish's primary practice is Scripps Memorial Hospital La Jolla in La Jolla, California, part of Scripps Health. Dr. Cavendish is also affiliated with Kaiser Permanente Zion Medical Center. The medical group on file is Southern California Permanente Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cavendish practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Cavendish's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Cavendish is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Cavendish's licenses on file in 3 states: California, Virginia and Pennsylvania.

Dmand AI lists chronic hypertension, heart attack and tobacco use among the conditions Dr. Cavendish treats.

CMS data shows 11 Medicare services from Dr. Cavendish across 1 procedure code in 2024, for 27 Medicare patients. Medicare paid $50 for them. Every service was in an office.

CMS counts 27 Medicare patients who saw Dr. Cavendish in 2024. The largest group is 65 to 74, with 13 patients. 74% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cavendish's median patient age at 71, with 40% women.

In 2024, Dr. Cavendish wrote 2,014 Medicare Part D claims for 340 patients. 88% of them were for generic drugs. CMS names the drug for 1,838 of them, across 32 drugs with 11 or more claims each, at $214,820 in total drug cost. In 2023, CMS named 1,865 claims across 31 drugs.

Dr. Cavendish accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Cavendish, published from 2007 to 2023. 2012 was the busiest year, with 3. The most frequent topics are Cardiac Catheterization, Coronary Artery Disease and Peripheral Vascular Diseases. Dr. Cavendish has published most often in Catheter Cardiovasc Interv. Dr. Cavendish's most frequent co-authors are Luther Ichiro Carter, MD, Ana Barac, MD and Barry Dean Bertolet, MD.

CMS Open Payments shows 120 general payments to Dr. Cavendish from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Abbott Laboratories paid the most, $14,843.

Dmand AI lists 2 awards for Dr. Cavendish, most recently CMS Stage 1 2012 in 2011.

Dr. Cavendish graduated from Georgetown University School Of Medicine in 1994. Dr. Cavendish is a member of ACC.

Dr. Cavendish is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.